nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—IFNG—Calcium signaling in the CD4+ TCR pathway—PRKACA—adrenal gland cancer	0.0298	0.0304	CbGpPWpGaD
Glucosamine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—DAXX—adrenal gland cancer	0.0247	0.0252	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—DAXX—adrenal gland cancer	0.022	0.0225	CbGpPWpGaD
Glucosamine—TNF—FAS pathway and Stress induction of HSP regulation—DAXX—adrenal gland cancer	0.0203	0.0208	CbGpPWpGaD
Glucosamine—MMP9—FGF signaling pathway—SPRY2—adrenal gland cancer	0.0197	0.0201	CbGpPWpGaD
Glucosamine—NFKB2—RANKL/RANK Signaling Pathway—CDC42—adrenal gland cancer	0.0187	0.0191	CbGpPWpGaD
Glucosamine—MMP9—Syndecan-1-mediated signaling events—PRKACA—adrenal gland cancer	0.0182	0.0186	CbGpPWpGaD
Glucosamine—MMP9—Osteopontin-mediated events—CDC42—adrenal gland cancer	0.0182	0.0186	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—PRKACA—adrenal gland cancer	0.0171	0.0175	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—adrenal gland cancer	0.0138	0.014	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—IGF1R—adrenal gland cancer	0.0135	0.0138	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—IGF1R—adrenal gland cancer	0.0135	0.0138	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—PRKACA—adrenal gland cancer	0.013	0.0133	CbGpPWpGaD
Glucosamine—IFNG—Calcium signaling in the CD4+ TCR pathway—PTGS2—adrenal gland cancer	0.013	0.0133	CbGpPWpGaD
Glucosamine—Streptozocin—ABCB1—adrenal gland cancer	0.0129	1	CrCbGaD
Glucosamine—NFKB2—Signaling by Interleukins—PRKACA—adrenal gland cancer	0.0129	0.0131	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—SPARC—adrenal gland cancer	0.0126	0.0129	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—PRKACA—adrenal gland cancer	0.012	0.0122	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—CDC42—adrenal gland cancer	0.0108	0.011	CbGpPWpGaD
Glucosamine—NFKB2—TWEAK Signaling Pathway—CTNNB1—adrenal gland cancer	0.0107	0.0109	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—ABCB1—adrenal gland cancer	0.0106	0.0109	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—TERT—adrenal gland cancer	0.0103	0.0105	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—CDC42—adrenal gland cancer	0.00993	0.0101	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—IGF2—adrenal gland cancer	0.00981	0.01	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00958	0.00978	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—IGF1R—adrenal gland cancer	0.00948	0.00968	CbGpPWpGaD
Glucosamine—IFNG—ATF-2 transcription factor network—RB1—adrenal gland cancer	0.00895	0.00913	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—MED12—adrenal gland cancer	0.00868	0.00887	CbGpPWpGaD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—adrenal gland cancer	0.00866	0.00884	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—BAD—adrenal gland cancer	0.00865	0.00883	CbGpPWpGaD
Glucosamine—TNF—Overview of nanoparticle effects—PTGS2—adrenal gland cancer	0.00845	0.00862	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IGF1R—adrenal gland cancer	0.00842	0.0086	CbGpPWpGaD
Glucosamine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—adrenal gland cancer	0.00839	0.00857	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—BRAF—adrenal gland cancer	0.00832	0.0085	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—CDC42—adrenal gland cancer	0.00823	0.0084	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—CDC42—adrenal gland cancer	0.00819	0.00836	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—BAD—adrenal gland cancer	0.00755	0.00771	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—CDC42—adrenal gland cancer	0.00748	0.00764	CbGpPWpGaD
Glucosamine—NFKB2—Cytosolic sensors of pathogen-associated DNA—CTNNB1—adrenal gland cancer	0.00742	0.00758	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—POMC—adrenal gland cancer	0.00709	0.00723	CbGpPWpGaD
Glucosamine—IFNG—TGF-beta Receptor Signaling—CTNNB1—adrenal gland cancer	0.00706	0.00721	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TERT—adrenal gland cancer	0.0069	0.00704	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.00686	0.007	CbGpPWpGaD
Glucosamine—TNF—Signaling events mediated by HDAC Class I—PRKACA—adrenal gland cancer	0.00684	0.00698	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—adrenal gland cancer	0.00683	0.00697	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—DAXX—adrenal gland cancer	0.00671	0.00685	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—BAD—adrenal gland cancer	0.0066	0.00674	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00659	0.00673	CbGpPWpGaD
Glucosamine—MMP9—TWEAK Signaling Pathway—CTNNB1—adrenal gland cancer	0.00654	0.00668	CbGpPWpGaD
Glucosamine—IFNG—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00636	0.00649	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CDC42—adrenal gland cancer	0.00624	0.00637	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00606	0.00618	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—PRKACA—adrenal gland cancer	0.006	0.00612	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—CDKN2A—adrenal gland cancer	0.00594	0.00606	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—BRAF—adrenal gland cancer	0.00574	0.00586	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.00574	0.00586	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—BAD—adrenal gland cancer	0.00571	0.00583	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—RB1—adrenal gland cancer	0.00564	0.00576	CbGpPWpGaD
Glucosamine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00564	0.00576	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00563	0.00575	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—BAD—adrenal gland cancer	0.00547	0.00559	CbGpPWpGaD
Glucosamine—TNF—FAS pathway and Stress induction of HSP regulation—RB1—adrenal gland cancer	0.00545	0.00556	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00534	0.00545	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NR5A1—adrenal gland cancer	0.00534	0.00545	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—EGFR—adrenal gland cancer	0.00528	0.00539	CbGpPWpGaD
Glucosamine—NFKB2—Neural Crest Differentiation—CTNNB1—adrenal gland cancer	0.00528	0.00539	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.0052	0.00531	CbGpPWpGaD
Glucosamine—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—adrenal gland cancer	0.00518	0.00529	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—RB1—adrenal gland cancer	0.00514	0.00525	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00507	0.00517	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—CTNNB1—adrenal gland cancer	0.00497	0.00507	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—CDKN2A—adrenal gland cancer	0.00496	0.00506	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—TP53—adrenal gland cancer	0.00494	0.00504	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—ABCB1—adrenal gland cancer	0.00494	0.00504	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—RB1—adrenal gland cancer	0.0049	0.005	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—PRKACA—adrenal gland cancer	0.00486	0.00496	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—IGF2—adrenal gland cancer	0.00483	0.00493	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—SH3KBP1—adrenal gland cancer	0.00475	0.00485	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—adrenal gland cancer	0.00467	0.00477	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1R—adrenal gland cancer	0.00467	0.00477	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—IGF1R—adrenal gland cancer	0.00467	0.00477	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—EGFR—adrenal gland cancer	0.00465	0.00475	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—SPARC—adrenal gland cancer	0.00457	0.00467	CbGpPWpGaD
Glucosamine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00457	0.00466	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.00435	0.00444	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.00422	0.00431	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.00416	0.00425	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—CTNNB1—adrenal gland cancer	0.00401	0.00409	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—TP53—adrenal gland cancer	0.004	0.00408	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—adrenal gland cancer	0.00391	0.00399	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—adrenal gland cancer	0.0039	0.00398	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—RB1—adrenal gland cancer	0.00389	0.00398	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—BRAF—adrenal gland cancer	0.00386	0.00394	CbGpPWpGaD
Glucosamine—IFNG—Immune System—SH3KBP1—adrenal gland cancer	0.00385	0.00393	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CDC42—adrenal gland cancer	0.00382	0.0039	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—TP53—adrenal gland cancer	0.00382	0.0039	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—BAD—adrenal gland cancer	0.00378	0.00385	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00373	0.00381	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—EGFR—adrenal gland cancer	0.0037	0.00378	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—BAD—adrenal gland cancer	0.00367	0.00375	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—EGFR—adrenal gland cancer	0.00361	0.00369	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.0036	0.00368	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—BAD—adrenal gland cancer	0.0035	0.00357	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00348	0.00355	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—PRKACA—adrenal gland cancer	0.00339	0.00346	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—PRKACA—adrenal gland cancer	0.00336	0.00343	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—TP53—adrenal gland cancer	0.00336	0.00343	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TP53—adrenal gland cancer	0.00331	0.00337	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—CTNNB1—adrenal gland cancer	0.00328	0.00335	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NR5A1—adrenal gland cancer	0.00327	0.00333	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—BAD—adrenal gland cancer	0.00325	0.00332	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MED12—adrenal gland cancer	0.00321	0.00327	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.0032	0.00327	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—EGFR—adrenal gland cancer	0.00299	0.00306	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00295	0.00301	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.00295	0.00301	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TP53—adrenal gland cancer	0.00289	0.00295	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—adrenal gland cancer	0.00289	0.00295	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—CDC42—adrenal gland cancer	0.00288	0.00294	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CDC42—adrenal gland cancer	0.00285	0.00291	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—CDC42—adrenal gland cancer	0.00278	0.00284	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TP53—adrenal gland cancer	0.00276	0.00282	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CDKN2A—adrenal gland cancer	0.00275	0.00281	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TP53—adrenal gland cancer	0.00263	0.00268	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TP53—adrenal gland cancer	0.00251	0.00257	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00248	0.00253	CbGpPWpGaD
Glucosamine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00246	0.00251	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00244	0.00249	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—RB1—adrenal gland cancer	0.00238	0.00243	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—adrenal gland cancer	0.0023	0.00235	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—EGFR—adrenal gland cancer	0.00227	0.00232	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—RB1—adrenal gland cancer	0.00221	0.00225	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—BAD—adrenal gland cancer	0.00214	0.00219	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GNRHR—adrenal gland cancer	0.00203	0.00207	CbGpPWpGaD
Glucosamine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00199	0.00203	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—BAD—adrenal gland cancer	0.00199	0.00203	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CDC42—adrenal gland cancer	0.00198	0.00203	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—EGFR—adrenal gland cancer	0.00197	0.00201	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MED12—adrenal gland cancer	0.00196	0.002	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.00196	0.002	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PRKACA—adrenal gland cancer	0.00196	0.002	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—adrenal gland cancer	0.00191	0.00194	CbGpPWpGaD
Glucosamine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0019	0.00194	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00189	0.00193	CbGpPWpGaD
Glucosamine—NFKB2—pituitary gland—adrenal gland cancer	0.00186	0.25	CbGeAlD
Glucosamine—TNF—Folate Metabolism—TP53—adrenal gland cancer	0.00186	0.0019	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—BRAF—adrenal gland cancer	0.00183	0.00187	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00181	0.00185	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00177	0.00181	CbGpPWpGaD
Glucosamine—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00175	0.00179	CbGpPWpGaD
Glucosamine—CYP2C19—urine—adrenal gland cancer	0.0017	0.228	CbGeAlD
Glucosamine—NFKB2—adrenal gland—adrenal gland cancer	0.00167	0.224	CbGeAlD
Glucosamine—NFKB2—Immune System—CDC42—adrenal gland cancer	0.00166	0.0017	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—CTNNB1—adrenal gland cancer	0.00162	0.00166	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—adrenal gland cancer	0.00161	0.00164	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PRKACA—adrenal gland cancer	0.00159	0.00162	CbGpPWpGaD
Glucosamine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00154	0.00157	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—adrenal gland cancer	0.00153	0.00156	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CTNNB1—adrenal gland cancer	0.00141	0.00144	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.0014	0.00143	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—EGFR—adrenal gland cancer	0.00139	0.00142	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CDC42—adrenal gland cancer	0.00135	0.00137	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.00133	0.00136	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CTNNB1—adrenal gland cancer	0.00131	0.00134	CbGpPWpGaD
Glucosamine—CYP2E1—urine—adrenal gland cancer	0.00125	0.168	CbGeAlD
Glucosamine—MMP9—Signaling Pathways—GNRH1—adrenal gland cancer	0.00122	0.00124	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CDC42—adrenal gland cancer	0.00121	0.00124	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.00119	0.00122	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—adrenal gland cancer	0.00117	0.00119	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—BAD—adrenal gland cancer	0.00116	0.00118	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SPRY2—adrenal gland cancer	0.00111	0.00114	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TSHR—adrenal gland cancer	0.00108	0.00111	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	0.00106	0.00108	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—EGFR—adrenal gland cancer	0.00105	0.00107	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—EGFR—adrenal gland cancer	0.00104	0.00106	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MEN1—adrenal gland cancer	0.00102	0.00104	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—EGFR—adrenal gland cancer	0.00101	0.00103	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SDHB—adrenal gland cancer	0.000946	0.000966	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000945	0.000965	CbGpPWpGaD
Glucosamine—IFNG—Immune System—BAD—adrenal gland cancer	0.00094	0.000959	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—adrenal gland cancer	0.000938	0.000957	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CTNNB1—adrenal gland cancer	0.000911	0.00093	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—adrenal gland cancer	0.000879	0.000898	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000816	0.000833	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000794	0.00081	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000788	0.000804	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PRKACA—adrenal gland cancer	0.000778	0.000794	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CTNNB1—adrenal gland cancer	0.000763	0.000779	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.00073	0.000745	CbGpPWpGaD
Glucosamine—MMP9—adrenal gland—adrenal gland cancer	0.000725	0.0974	CbGeAlD
Glucosamine—MMP9—Developmental Biology—EGFR—adrenal gland cancer	0.000722	0.000737	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CDC42—adrenal gland cancer	0.00066	0.000674	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IGF2—adrenal gland cancer	0.000636	0.000649	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GNAS—adrenal gland cancer	0.00063	0.000644	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CTNNB1—adrenal gland cancer	0.000618	0.000631	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IGF1R—adrenal gland cancer	0.000615	0.000628	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—RRM1—adrenal gland cancer	0.00061	0.000622	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SDHD—adrenal gland cancer	0.00061	0.000622	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—EGFR—adrenal gland cancer	0.000605	0.000617	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000574	0.000586	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CTNNB1—adrenal gland cancer	0.000558	0.000569	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TERT—adrenal gland cancer	0.000529	0.00054	CbGpPWpGaD
Glucosamine—IFNG—Immune System—EGFR—adrenal gland cancer	0.00049	0.0005	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.00047	0.00048	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.00047	0.00048	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—BAD—adrenal gland cancer	0.00046	0.00047	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—MED12—adrenal gland cancer	0.000455	0.000464	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—EGFR—adrenal gland cancer	0.000442	0.000451	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—POMC—adrenal gland cancer	0.000425	0.000433	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—BRAF—adrenal gland cancer	0.000419	0.000428	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000351	0.000358	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	0.000332	0.000339	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000314	0.00032	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000303	0.000309	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GNAS—adrenal gland cancer	0.000269	0.000274	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	0.000264	0.000269	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.000256	0.000261	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00025	0.000255	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EGFR—adrenal gland cancer	0.00024	0.000245	CbGpPWpGaD
Glucosamine—CYP2E1—adrenal gland—adrenal gland cancer	0.000239	0.0321	CbGeAlD
Glucosamine—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000207	0.000212	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000203	0.000208	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—adrenal gland cancer	0.000202	0.000206	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—POMC—adrenal gland cancer	0.000181	0.000185	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	0.000144	0.000147	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—POMC—adrenal gland cancer	0.00014	0.000143	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	0.000111	0.000114	CbGpPWpGaD
